Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty
Status:
Unknown status
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether very low dose of preoperative tranexamic
acid (5mg/kg) is as effective as low dose (10mg/kg) for intraoperational bleeding reduction
in patients undergoing elective rhinoplasty surgery.